Scotch Plains, NJ, United States of America

Leonardus H T Van Der Ploeg

This inventor holds 32 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Merck + Co., Inc., Rhythm Pharmaceuticals, Inc., Deuterx, LLC. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonardus H T Van Der Ploeg. Retrieved from https://idiyas.com/inventor/leonardus-h-t-van-der-ploeg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 71.9

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 295(Granted Patents)


Location History:

  • Sctoch Plains, NJ (US) (2003)
  • ScotchPlains, NJ (US) (2001 - 2008)
  • Newton, MA (US) (2007 - 2024)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Melanocortin-4 Receptor
Peptide Compositions
Neurological Disorders
Transgenic Mouse
Deuterium-Enriched Bupropion
Growth Hormone Secretagogue
Spiropiperidine Derivatives
DNA Molecules
Assays
Metabolic Disorders
Alzheimer's Disease
32 patents (USPTO):Explore Patents

As an AI assistant at idiyas.com, I can write an article about inventor Leonardus H T Van Der Ploeg for you.

Title: Innovator Spotlight - Leonardus H T Van Der Ploeg: Pushing Boundaries in Pharmaceutical Innovation

Introduction:

Leonardus H T Van Der Ploeg, a distinguished inventor based in Scotch Plains, NJ (US), has made significant contributions to the field of pharmaceuticals with a total of 26 patents to his name.

Latest Patents:

1. Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers: Van Der Ploeg's innovative method involves administering an agonist of the melanocortin-4 receptor (MC4R) to address disorders in subjects who are heterozygous carriers of an MC4R mutation.

2. Pharmaceutical compositions: He developed an ionic complex comprising a cationic polypeptide and an anionic excipient for pharmaceutical compositions. This complex offers a more favorable pharmacokinetic profile for the cationic polypeptide, enhancing its therapeutic benefits.

Career Highlights:

Van Der Ploeg has left an indelible mark on the industry through his work with renowned companies such as Merck & Co. and Rhythm Pharmaceuticals. His dedication to advancing pharmaceutical science has paved the way for novel treatment options.

Collaborations:

Throughout his career, Leonardus H T Van Der Ploeg has collaborated closely with esteemed colleagues, including Andrew D Howard and Bart Henderson. Together, they have spearheaded groundbreaking research initiatives that have reshaped the landscape of pharmaceutical innovation.

Conclusion:

Leonardus H T Van Der Ploeg's inventive spirit and unwavering commitment to excellence underscore his position as a pioneering figure in the realm of pharmaceutical inventions. His patent portfolio stands as a testament to his relentless pursuit of advancements in medical science, making him a revered figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…